ARDELYX INC. - COMMON STOCK
5.3100
22-11月-24 16:44:58
15 分の遅延
株式
+0.1900
+3.71%
本日の幅
5.0600 - 5.3450
ISIN
N/A
ソース
NASDAQ
-
31 10 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
30 10 2023 17:42:57 提供 Nasdaq GlobeNewswire
-
23 10 2023 08:07:01 提供 Nasdaq GlobeNewswire
-
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
18 10 2023 16:02:39 提供 Nasdaq GlobeNewswire
-
17 10 2023 19:23:38 提供 Nasdaq GlobeNewswire
-
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
17 10 2023 19:01:06 提供 Nasdaq GlobeNewswire
-
13 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
28 9 2023 08:02:00 提供 Nasdaq GlobeNewswire
-
Tenapanor for Hyperphosphatemia Approved in Japan
25 9 2023 04:15:13 提供 Nasdaq GlobeNewswire
-
11 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
07 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
02 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
27 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
26 7 2023 07:55:00 提供 Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
20 7 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
13 7 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
29 6 2023 16:09:08 提供 Nasdaq GlobeNewswire
-
05 6 2023 08:00:01 提供 Nasdaq GlobeNewswire